Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity

Lawal Danjuma, Pooi Ling Mok, Akon Higuchi, Rukman Awang Hamat, Seoh Wei Teh, Avin Ee Hwan Koh, Murugan A. Munusamy, Palanisamy Arulselvan, Mariappan Rajan, Arivudai Nambi, K. B. Swamy, Kiruthiga Vijayaraman, Kadarkarai Murugan, Kalimuthusamy Natarajaseenivasan, Suresh Kumar Subbiah

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Introduction: Anti-tuberculosis agent rifampicin is extensively used for its effectiveness. Possible complications of tuberculosis and prolonged rifampicin treatment include kidney damage; these conditions can lead to reduced efficiency of the affected kidney and consequently to other diseases. Bone marrow-derived mesenchymal stem cells (BMMSCs) can be used in conjunction with rifampicin to avert kidney damage; because of its regenerative and differentiating potentials into kidney cells. This research was designed to assess the modulatory and regenerative potentials of MSCs in averting kidney damage due to rifampicin-induced kidney toxicity in Wistar rats and their progenies. BMMSCs used in this research were characterized according to the guidelines of International Society for Cellular Therapy. Methods: The rats (male and female) were divided into three experimental groups, as follows: Group 1: control rats (4 males & 4 females); Group 2: rats treated with rifampicin only (4 males & 4 females); and Group 3: rats treated with rifampicin plus MSCs (4 males & 4 females). Therapeutic doses of rifampicin (9 mg/kg/day for 3-months) and MSCs infusions (twice/month for 3-months) were administered orally and intravenously respectively. At the end of the three months, the animals were bred together to determine if the effects would carry over to the next generation. Following breeding, the rats were sacrificed to harvest serum for biochemical analysis and the kidneys were also harvested for histological analysis and quantification of the glomeruli size, for the adult rats and their progenies. Results: The results showed some level of alterations in the biochemical indicators and histopathological damage in the rats that received rifampicin treatment alone, while the control and stem cells treated group showed apparently normal to nearly normal levels of both bio-indicators and normal histological architecture. Conclusions: Intravenous administration of MSCs yielded sensible development, as seen from biochemical indicators, histology and the quantitative cell analysis, hence implying the modulatory and regenerative properties of MSCs.

Original languageEnglish
Pages (from-to)100-110
Number of pages11
JournalRegenerative Therapy
StatePublished - Dec 2018


  • Histopathology
  • Kidney
  • Mesenchymal stem cells
  • Rifampicin
  • Stem cell therapy
  • Tuberculosis


Dive into the research topics of 'Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity'. Together they form a unique fingerprint.

Cite this